External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Dermatology

Dermatology

Diseases
Pemphigus Vulgaris

Preview the lastest medical materials

  • Dermatology

Sign up or login to unlock the full suite of MEDICALLY features
Oct 28 / Roche and Genentech
Phase III Clinical Trials for Omalizumab and Remibrutinib for Patients With Chronic Spontaneous Urticaria
This poster compared the study designs of primary phase 3 trials for omalizumab and remibrutinib in patients with CSU. This comparison may aid in the clinical evaluation of efficacy and safety outcomes for patients with CSU.
Dermatology Chronic Idiopathic Urticaria Fall-CDC-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 28 / Roche and Genentech
Efficacy Outcomes in Phase III Trials for Omalizumab and Dupilumab for Patients With Chronic Spontaneous Urticaria
This poster compared efficacy outcomes of primary phase 3 trials for omalizumab and dupilumab in patients with CSU. This comparison may aid in the management of patients with CSU.
Dermatology Chronic Idiopathic Urticaria Fall-CDC-2024

Sign up or login to unlock the full suite of MEDICALLY features
Nov 11 / Roche and Genentech
HCP Interview: Experience on the treatment of PV patients and recent clinical trial data
In this interview, a prominent expert in pemphigus share his experience on the treatment of PV patients and recent clinical trial data.
Dermatology Pemphigus Vulgaris EADV-2019
View full list of congress materials
Upcoming congresses
Access to Roche and Genentech's latest medical information
View related congresses

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.